Payment scheduled for mid-November… advancing plans to supply health supplements and skincare products to Japan
Health and bio company Hurum is entering the Japanese market by investing KRW 2 billion in Japanese medical device distributor Biomedical Net.
Hurum announced on the 27th that its board of directors met on the 26th and resolved to acquire convertible bonds (CB) issued by Biomedical Net worth approximately KRW 2 billion. Payment will be completed in mid-next month. Having focused its exports on China, Southeast Asia, and Central Asia, Hurum plans to use this investment as a springboard to expand its sales channels into Japan.
Established in 2002, Biomedical Net is an online medical device retailer. Through its own shopping mall “Shop de Clinic,” it sells medical devices and hospital consumables, and it also operates stores on Rakuten and Amazon Japan. The company stated that it ranks first in sales in the medical device category on both platforms. Its annual sales are around JPY 4.1 billion (approximately KRW 34 billion), with 800,000 annual users and a cumulative customer base of about 10 million. It also has its own products, such as the stem cell culture supernatant brand “PURESTEM” and the electric nasal irrigator “NOPPY.”
Once the payment is completed, Hurum plans to supply its own health functional foods and the skin beauty and bio-medical products of its subsidiary YU to Japan through Biomedical Net’s distribution network to hospitals and clinics as well as its online channels. The two companies also agreed to pursue joint research and development in the skin beauty and bio sectors.
Kim Jin-seok, CEO of Hurum, said, “As soon as payment is completed in November, we will begin supplying health functional foods and aesthetic products to Japan.”
Founded in 2005, Hurum is a KOSDAQ-listed company that manufactures health functional foods and skin beauty products based on functional natural materials and exports them to countries including China, Vietnam, and Kazakhstan.
Choi Yong-seok
AI-translated with ChatGPT. Provided as is; original Korean text prevails.
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.